Meeting
2019 ASCO Annual Meeting
Blood-based genomic profiling of cell-free DNA (cfDNA) to identify microsatellite instability (MSI-H), tumor mutational burden (TMB) and Wnt/B-Catenin pathway alterations in patients with gastrointestinal (GI) tract cancers.
Authors
James Isaacs
Duke University, Durham, NC
James Isaacs , Andrew B. Nixon , Emily Bolch , Katie Quinn , Kimberly Banks , Brent Allen Hanks , John H. Strickler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3552)
DOI
10.1200/JCO.2019.37.15_suppl.3552
Abstract #
3552
Poster Bd #
44
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).
First Author: Chris Alan Karlovich
Poster
2023 ASCO Annual Meeting
Gynecologic-cancer analysis of ARID1A alterations detected in tissue and liquid biopsies.
First Author: Natalie Danziger
Poster
2021 ASCO Annual Meeting
Genomic immunotherapy (IO) biomarkers detected on comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA).
First Author: Takayuki Yoshino
Poster
2018 ASCO Annual Meeting
MSI-high and MSI-stable colorectal carcinomas (CRC): A comprehensive genomic profiling (CGP) study.
First Author: Siraj Mahamed Ali